Genicular Nerve Block After Open Reduction Internal Fixation of Tibial Plateau

Conditions

• Tibial Plateau Fractures

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Bupivacain — DRUG
  5mL 0.25% bupivacain

Study Details

The investigators are conducting this research study to find better ways of treating pain following knee surgery. There is a standard (accepted) approach, which involves injection of numbing medication into the area around the participant surgical incision. The investigators hope to discover if providing numbing medication to a nerve that controls pain in a larger area of the knee (a nerve block), might be better at post-operative pain control.

Key Dates

Start date

Nov 1, 2024

Status verified

Feb 2026

Primary completion

Sep 1, 2026

Completion

Oct 14, 2026

Study Design

Enrollment

38 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Arms

• No Intervention: Peri-incisional local anesthesia
  subjects randomized to peri-incisional local anesthesia administration will receive an injection of 25 ml of 0.25% bupivacaine across all incisions at the time of wound closure (standard of care)
• Experimental: Genicular nerve blockade
  Subjects randomized to genicular nerve block will receive a fluoroscopic guided injection of 5 ml of 0.25% bupivacaine at the described locations of the superolateral genicular nerve, super medial genicular nerve, inferomedial genicular nerve, recurrent fibular nerve, and infrapatellar branch of the saphenous nerve under fluoroscopic guidance at the time of wound closure

Primary Outcome Measure

Pain Ratings from Visual Analog Scale (VAS) [ Time Frame: one hour, two hours, and discharge from PACU ]

Central Contacts

• Anthony Christiano, MD
  773-834-3531
  [email protected]

Locations (1)

Find similar trials in Chicago, IL